Smart Trading Field
  • Politics
  • Investing
  • Tech News
  • Stock
  • Editor’s Pick
Investing

The Endless Search for a Surgeon General We Don’t Need

by April 30, 2026
by April 30, 2026 0 comment

Jeffrey A. Singer

doctor

On November 24, 2024, before taking office to start his second term, then-President-elect Trump nominated Dr. Janette Neshiewat, a Fox News medical commentator, to become the next Surgeon General of the United States. Because of controversies surrounding her resumé, the White House withdrew her nomination on May 7, 2025. Shortly thereafter, President Trump nominated Dr. Casey Means for the post. 

Dr. Means’ Senate confirmation hearings were delayed due to the birth of her baby, but finally began on February 25, 2026. Dr. Means’ nomination was controversial due to unorthodox positions on health and wellness, questions about her belief in vaccinations, her failure to complete a postgraduate residency program, and the inactivity of her medical license.

With her confirmation in doubt, the White House announced today that it is withdrawing Dr. Means’ nomination and returning to the Fox News bench to nominate Fox News medical commentator and radiologist at New York’s Memorial Sloan Kettering Cancer Center, Dr. Nicole Saphier.

At the beginning of this month, I wrote. “America Has Gone More Than a Year Without a Surgeon General—Has Anyone Noticed?” With Dr. Saphier’s credentials requiring Senate scrutiny and confirmation, it might be two years before America finally gets to find out who will be “the nation’s doctor.” But as the 70s rock group Humble Pie famously said, we “don’t need no doctor.”

As I’ve written before, this exercise is unnecessary. My colleagues and I explained in a Cato policy analysis nearly a year ago that the Office of the Surgeon General and the Public Health Service Commissioned Corps, which the office oversees, are unnecessary relics. The surgeon general has drifted from an apolitical public health role into a politicized platform, weighing in on issues far beyond its proper scope—from gun control to social policy—thereby undermining trust in legitimate health functions. 

Rather than wasting the Senate’s time on what could become another contentious confirmation process, Congress should end this mission creep by dissolving the Office of the Surgeon General and the Commissioned Corps and reassigning any truly necessary public health duties to existing agencies.

A year without a surgeon general hasn’t left Americans sicker—it’s just left Washington with one less bully pulpit. That’s not a problem to fix. It’s an opportunity to finally shut the office down.

0 comment
0
FacebookTwitterPinterestEmail

previous post
FCC’s Punitive Review of ABC-Disney’s Broadcast Licenses Shows Need to Protect Free Expression
next post
OPEC and the UAE Exit

You may also like

The AI Boom Is Being Fueled by Imports—and...

April 30, 2026

OPEC and the UAE Exit

April 30, 2026

FCC’s Punitive Review of ABC-Disney’s Broadcast Licenses Shows...

April 30, 2026

The FISA Section 702 Lapse “Going Dark” Myth

April 30, 2026

The AI Policy Questions in the Underlying Issues...

April 30, 2026

House Votes to Continue Subverting the Fourth Amendment

April 29, 2026

Who Should Govern Surgical AI? Not the FDA—and...

April 29, 2026

GUARD Act Puts Policymakers, Not Parents, in Charge...

April 29, 2026

Will Louisiana v. Callais Close the Door on...

April 29, 2026

Apply to Cato University 2026: Criminal Justice Symposium

April 29, 2026

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 smarttradingfield.com | All Rights Reserved

    Smart Trading Field
    • Politics
    • Investing
    • Tech News
    • Stock
    • Editor’s Pick